Press Releases InnoCan Pharma Corporation

Equities

INNO

CA45783P1027

Market Closed - Canadian Securities Exchange Other stock markets 03:47:28 2024-04-26 pm EDT			5-day change	1st Jan Change
0.28 ^CAD	+1.82%		+3.70%	-9.68%

Apr. 01	InnoCan Pharma Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 25	Innocan Pharma Corporation Announces the Signing of an Agreement with the Hebrew University	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain	Apr. 22	AQ
Innocan Pharma Reports Full Year 2023 Results with Revenues up Nearly 6X to $13.7M	Apr. 01	AQ
Innocan Pharma paves its way to LPT-CBD Chemistry, Manufacturing and Controls (CMC), key milestones for FDA approval.	Mar. 25	AQ
Innocan Pharma Announces Closing of Private Placement for Gross Proceeds of Approximately C$2 Million	Mar. 14	AQ
Innocan Pharma's LPT-CBD Has the Potential to Support a new Therapeutic Venue for Neurological Disorders According to Recent Study	Mar. 05	AQ
Innocan Pharma Announces Study Findings that LPT-CBD maintains its prolonged release in Rabbits	Feb. 26	AQ
Innocan Pharma to participate in the White Label World Expo on February 27-28th, 2024	Feb. 20	AQ
Innocan Provides Corporate Update & Preliminary Q4 and Fiscal Year 2023 Financial Highlights	Feb. 13	AQ
Innocan Pharma to provide a corporate update via Zoom livestream on February 12, 2024, at 4:00pm EST	Feb. 05	AQ
Innocan Pharma Announces Expert Team for LPT CBD Application to United States Food and Drug Administration	Dec. 12	AQ
Innocan Pharma Reports Q3 2023 Results Including US$3.334M Increase in Revenues Compared to Q3, 2022	Nov. 29	AQ
Innocan Pharma Announces Promising LPT-CBD Safety Indications -Implications from a prolong use in animals	Nov. 03	AQ
Innocan Pharma reports a groundbreaking discovery regarding its LPD platform and global CBD research	23-10-23	AQ
Innocan Pharma Announces Closing of Second and Final Tranche of Financing	23-10-20	AQ
Innocan Pharma Announces Closing of First Tranche Private Placement and Provides Corporate Update	23-10-12	AQ
Innocan Pharma Announces Brokered LIFE Offering of Units for Up to $3 Million	23-09-21	GL
Innocan Pharma Announces the Addition of Dr. Joseph V. Pergolizzi, Jr., M.D. to its Advisory Board	23-09-15	AQ
Innocan Pharma Announces Promising Results from Hair Care Cream Efficacy Test	23-09-05	AQ
Innocan Pharma Announces Clinical Study Results: Evidence of Reduced Osteoarthritis Pain in Dogs After Liposomal CBD Injection	23-08-29	AQ
Innocan Pharma Reports Q2 2023 Results Including US$2.706M Increase in Revenues Compared to Q2, 2022	23-08-25	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases InnoCan Pharma Corporation

Equities

INNO

CA45783P1027

Press Releases

Filters